- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 25, 2025 | 19.82M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 19.24M sh |
| Capex | FY 2024 · Dec 31, 2023 | $93K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$647K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $3.98M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $6.53M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $6.53M |
| Current Assets | FY 2024 · Dec 31, 2023 | $14.38M |
| Total Assets | FY 2024 · Dec 31, 2023 | $23.81M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.10 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.10 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $15.13M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $4.68M |
| Net Income | FY 2024 · Dec 31, 2023 | −$1.98M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$2.28M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $17.53M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $1.38M |
| Revenue | FY 2024 · Dec 31, 2023 | $18.91M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $17.67M |